David Brill
Family Medicine · Columbus, OHNPI 1851311559
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 230 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,512 and has fallen 98.8% since, to $29 in 2023.
Across 230 payments — averaging $13.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$409
- Johnson & Johnson$315
- Novo Nordisk$220
- AstraZeneca$207
- Merck$197
- Viiv Healthcare Company$182
- plus $2K from 28 others
What the payments were for
- Food & beverage$2,92295%
- Education$1635%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 40 | $409 |
| Johnson & Johnson(2 entities) | 27 | $315 |
| Novo Nordisk | 20 | $220 |
| AstraZeneca | 16 | $207 |
| Merck | 18 | $197 |
| Viiv Healthcare Company | 12 | $182 |
| GSK | 15 | $172 |
| AbbVie(2 entities) | 9 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $116 |
| Astellas Pharma US Inc | 6 | $105 |
| Janssen Products, LP | 1 | $99 |
| Pfizer | 6 | $80 |
| Gilead | 5 | $78 |
| Antares Pharma, Inc. | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $61 |
| Rhodes Pharmaceuticals L.p. | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Alkermes, Inc. | 2 | $47 |
| Lilly USA, LLC | 3 | $46 |
| Arbor Pharmaceuticals, Inc. | 3 | $44 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Novartis | 3 | $39 |
| Boehringer Ingelheim | 2 | $33 |
| Circassia Inc. | 2 | $32 |
| Genentech USA, Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $20 |
| Napo Pharmaceuticals Inc | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
How this compares
$3,086 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $1,049 |
| Trazodone Hcl | 15 | $35 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Columbus
- Brian BeesleyColumbus$1.4M
- Kwabena OtengSpringdale$2M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.